TNGX — Tango Therapeutics Share News
0.000.00%
Last trade - 00:00- $3.83bn
- $2.81bn
- $62.38m
Brief: Tango Therapeutics Announces Combination Of Vopimetostat And Daraxonrasib Demonstrated 92% Objective Response Rate In Pancreatic Cancer
Brief: Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
U.S. RESEARCH ROUNDUP- Applied Materials, NVIDIA, Thermo Fisher Scientific
U.S. RESEARCH ROUNDUP- Cisco, DTE Energy, Marvell Technology
Tango Therapeutics Q1 net loss widens as collaboration revenue falls
Brief: Tango Therapeutics Q1 Basic EPS USD -0.32
U.S. STOCKS ON THE MOVE-Nike, PNC Financia, OSI Systems
U.S. STOCKS ON THE MOVE-Nike, PNC Financial, Papa John's
Tango Therapeutics rises after leadership changes ahead of cancer drug data
Brief: Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Erasca rises on partnership with Tango to test new cancer drug combo
Tango Therapeutics Q4 net loss widens
Brief: Erasca And Tango Therapeutics Enter Into Clinical Collaboration To Evaluate Combination Of ERAS-0015 And Vopimetostat
Brief: Tango Therapeutics Announces CEO Transition Barbara Weber To Retire, Malte Peters Appointed Successor
Brief: Tango Therapeutics Inc Files For Mixed Shelf Offering - SEC Filing
Brief: Tango Therapeutics Files Prospectus For Resale Of 1.7 Million Shares By Selling Stockholder - SEC Filing
Trump pardons British billionaire Joe Lewis
Tango Therapeutics reports Q3 net income, revenue jumps
U.S. STOCKS ON THE MOVE-LendingClub, Hasbro, Intel